Skip to main content

Vaccines

Vaccine Research Site Capabilities

Ideal Clinical Research has been conducting high-enrollment vaccine trials in underserved communities since 2013. Our experienced team ensures efficient recruitment, high-quality data collection, and full regulatory compliance.

Expert Medical Team

Our board-certified Principal Investigators (PIs) and Sub-Investigators have extensive clinical trial and vaccine research experience across multiple therapeutic areas.

Participant Recruitment & Retention

  • Diverse Recruitment Channels: We access multiple databases, including private practice records, electronic medical records, and our proprietary research database.
  • Community Outreach: Strong partnerships with community organizations, assisted living facilities, and healthcare networks.
  • Advanced Screening: Biometric scanning prevents dual enrollment and ensures subject integrity.
  • Retention Strategies: Personalized follow-ups, transportation assistance, and engagement programs to maximize retention.

Experienced Clinical Research Team

  • Skilled CRCs: Our Clinical Research Coordinators average 8 years of trial experience, ensuring compliance and patient safety.
  • Blinded & Unblinded Teams: Dedicated teams maintain study integrity.
  • Regulatory Expertise: Deep knowledge of FDA, IRB, and sponsor requirements ensures strict compliance.

Regulatory Compliance & Data Security

  • Skilled CRCs: Our Clinical Research Coordinators average 8 years of trial experience, ensuring compliance and patient safety.
  • Blinded & Unblinded Teams: Dedicated teams maintain study integrity.
  • Regulatory Expertise: Deep knowledge of FDA, IRB, and sponsor requirements ensures strict compliance.

Proven Track Record

  • High-Enrollment Studies: Consistently exceeding vaccine recruitment goals.
  • Strong Industry Relationships: Trusted by leading pharmaceutical companies, and CROs.
  • Diverse Participant Pool: Enhancing study impact through inclusive recruitment.

Ideal Clinical Research is dedicated to advancing vaccine development with expertise, technology, and patient-centered care.

5
Therapeutic Areas
25
Trial Experience
400
Trials Conducted
32,000
Patient Database